$NASDAQ:GH

Guardant Health Stock Fair Value Calculation – Guardant Health Reports Impressive Revenue Growth in Third Quarter 2024, EPS Falls Short of Expectations

☀️Trending News Guardant Health ($NASDAQ:GH) is a leading precision oncology company that specializes in non-invasive cancer diagnostics and comprehensive genomic [...]

By |November 12, 2024|Categories: Diagnostics & Research|Tags: , , |0 Comments

Leerink Partners lowers price target for Guardant Health, but maintains “outperform” rating on stock

🌧️Trending News Guardant Health ($NASDAQ:GH) is a precision oncology company that specializes in developing and commercializing blood tests for early [...]

By |October 24, 2024|Categories: Diagnostics & Research, Market Price|Tags: , , |0 Comments

Guardant Health Raises $90.7 Million in Registered Direct Offering with Baillie Gifford

🌥️Trending News Guardant Health ($NASDAQ:GH), a leading precision oncology company, recently raised $90.7 million in a Registered Direct Offering with [...]

By |December 26, 2023|Categories: Diagnostics & Research|Tags: , , |0 Comments

GUARDANT HEALTH Reports 21.8% Year-Over-Year Revenue Increase in Q3 of FY2023, Net Income Decreases -162.0 Million

☀️Earnings Overview For the third quarter of FY2023 ending September 30 2023, GUARDANT HEALTH ($NASDAQ:GH) reported total revenue of USD [...]

Guardant Health Set to Reveal Q2 Earnings: Evaluating Performance and Future Potential

🌥️Introduction: Guardant Health, a pioneering precision oncology company, is gearing up to announce its second-quarter earnings on August 3, 2023, [...]

GUARDANT HEALTH Reports 25.7% Increase in Total Revenue for Q2 FY2023 at $137.2 Million

☀️Earnings Overview GUARDANT HEALTH ($NASDAQ:GH) reported total revenue of USD 137.2 million for the second quarter of FY2023, a 25.7% [...]

Go to Top